Everence Capital Management Inc Cara Therapeutics, Inc. Transaction History

Everence Capital Management Inc

  • $1.51 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023
BUY
$8.88 - $12.77 $98,923 - $142,257
11,140 New
11,140 $120,000
Q1 2022

Apr 11, 2022
SELL
$9.94 - $12.65 $172,260 - $219,224
-17,330 Closed
0 $0
Q4 2021

Jan 28, 2022
BUY
$11.99 - $18.14 $207,786 - $314,366
17,330 New
17,330 $211,000

Others Institutions Holding CARA

# of Institutions
102
Shares Held
21.5M
Call Options Held
50K
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $14M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Everence Capital Management Inc Portfolio

Follow Everence Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Everence Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email